Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
Acrivon Therapeutics
ACRV
$64.2M
| $233K | ﹤0.01% |
33,306
+11,273
| +51% | +$88.8K |
|
4102
AudioEye
AEYE
$72.3M
| $233K | ﹤0.01% |
10,181
+2,788
| +38% | +$61.4K |
|
4103
Acacia Research
ACTG
$428M
| $232K | ﹤0.01% |
49,788
+35,685
| +253% | +$176K |
|
4104
CALL
MetLife
MET
$61.9B
| $231K | ﹤0.01% |
2,800
-476,700
| -99% | -$35.6M |
|
|
AFCG
4105
AFC Gamma
AFCG
$61.4M
| $230K | ﹤0.01% |
22,567
+13,331
| +144% | +$129K |
|
4106
Bel Fuse Inc Class A
BELFA
$3.17B
| $230K | ﹤0.01% |
2,311
+1,701
| +279% | +$148K |
|
4107
Symbotic
SYM
$5.48B
| $228K | ﹤0.01% |
9,346
+8,571
| +1,106% | +$233K |
|
|
FSP
4108
Franklin Street Properties
FSP
$47.2M
| $227K | ﹤0.01% |
128,258
+94,274
| +277% | +$157K |
|
4109
Skye Bioscience
SKYE
$20M
| $226K | ﹤0.01% |
57,889
+15,551
| +37% | +$87.2K |
|
4110
Achieve Life Sciences
ACHV
$659M
| $226K | ﹤0.01% |
47,655
+35,832
| +303% | +$164K |
|
4111
Comp X International
CIX
$349M
| $225K | ﹤0.01% |
7,700
+1,550
| +25% | +$41.1K |
|
4112
National Bankshares
NKSH
$259M
| $224K | ﹤0.01% |
7,487
+5,569
| +290% | +$165K |
|
4113
Holley
HLLY
$321M
| $224K | ﹤0.01% |
75,795
+56,277
| +288% | +$189K |
|
4114
Eastern Company
EML
$143M
| $223K | ﹤0.01% |
6,875
+5,055
| +278% | +$148K |
|
|
ORAN
4115
DELISTED
Orange
ORAN
| $222K | ﹤0.01% |
19,380
-14,288
| -42% | -$162K |
|
4116
AerSale
ASLE
$293M
| $222K | ﹤0.01% |
44,003
+31,996
| +266% | +$185K |
|
4117
UWM Holdings
UWMC
$617M
| $222K | ﹤0.01% |
26,022
+21,579
| +486% | +$182K |
|
4118
Dakota Gold
DC
$608M
| $221K | ﹤0.01% |
93,667
+69,896
| +294% | +$160K |
|
4119
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
| $220K | ﹤0.01% |
1,745
| – | – |
|
4120
Loar Holdings
LOAR
$6.41B
| $220K | ﹤0.01% |
2,943
+2,640
| +871% | +$175K |
|
4121
Kimbell Royalty Partners
KRP
$1.48B
| $219K | ﹤0.01% |
13,605
+12,538
| +1,175% | +$202K |
|
4122
Shell
SHEL
$254B
| $218K | ﹤0.01% |
3,312
-1,650
| -33% | -$117K |
|
|
MODV
4123
DELISTED
ModivCare
MODV
| $218K | ﹤0.01% |
15,235
+10,875
| +249% | +$249K |
|
4124
Full House Resorts
FLL
$80.1M
| $217K | ﹤0.01% |
43,247
+31,512
| +269% | +$160K |
|
|
DADA
4125
DELISTED
Dada Nexus
DADA
| $216K | ﹤0.01% |
113,921
-25,000
| -18% | -$32.7K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.